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Abstract
Background: Multimorbidity is the coexistence of more than two chronic diseases in the same individual; however,
there is no consensus about the best definition. In addition, few studies have described the variability of multimorbidity
patterns over time. The aim of this study was to identify multimorbidity patterns and their variability over a
6-year period in patients older than 65 years attended in primary health care.
Methods: A cohort study with yearly cross-sectional analysis of electronic health records from 50 primary health care
centres in Barcelona. Selected patients had multimorbidity and were 65 years of age or older in 2009. Diagnoses
(International Classification of Primary Care, second edition) were extracted using O’Halloran criteria for chronic
diseases. Multimorbidity patterns were identified using two steps: 1) multiple correspondence analysis and 2) k-means
clustering. Analysis was stratified by sex and age group (65–79 and ≥80 years) at the beginning of the study period.
Results: Analysis of 2009 electronic health records from 190,108 patients with multimorbidity (59.8% women) found a
mean age of 71.8 for the 65–79 age group and 84.16 years for those over 80 (Standard Deviation [SD] 4.35 and 3.46,
respectively); the median number of chronic diseases was seven (Interquartil range [IQR] 5–10). We obtained 6 clusters
of multimorbidity patterns (1 nonspecific and 5 specifics) in each group, being the specific ones: Musculoskeletal,
Endocrine-metabolic, Digestive/Digestive-respiratory, Neurological, and Cardiovascular patterns. A minimum of 42.
5% of the sample remained in the same pattern at the end of the study, reflecting the stability of these patterns.
Conclusions: This study identified six multimorbidity patterns per each group, one nonnspecific pattern and five
of them with a specific pattern related to an organic system. The multimorbidity patterns obtained had similar
characteristics throughout the study period. These data are useful to improve clinical management of each specific
subgroup of patients showing a particular multimorbidity pattern.
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Background
Multimorbidity is defined as the coexistence of two or
more chronic diseases [1, 2]. Although overall life expect-
ancy and healthy life years have increased worldwide,
quality of life and functional capacity has worsened [3]
due to the chronic conditions strongly related to aging.
Some studies predict a rise in prevalence of these
conditions [4]; population multimorbidity prevalence cur-
rently ranges from 12.9% to 95.1% [5]. In addition, rates of
hospitalization and treatment for people with chronic dis-
eases have soared; consequently, a growth in the burden
of disease on health systems is assumed in general, and in
primary health care in particular [3].
Although life expectancy has increased in the last cen-
tury [3], research on multimorbidity has been limited
and has focused on describing prevalence, estimating
severity, and assessing quality of life [6, 7].
In clinical practice, individual patients often present
with a collection of chronic diseases which may or may
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not have a common aetiology, but which require greatly
differing and often incompatible management. Preva-
lence studies, mostly with transversal designs, have iden-
tified multimorbidity patterns in patients older than
65 years, but few prospective longitudinal studies have
been published and none of them have analysed a period
longer than 4 years [5]. With better knowledge about
the evolution of multimorbidity patterns, the joint man-
agement of several chronic diseases simultaneously
could be more effective.
On the other hand, most of the published studies con-
sidered diseases, not individuals, as the variable of ana-
lysis in assessing multimorbidity patterns. This inhibits
an exploration of multimorbidity patterns that takes into
account their trajectories and evolution along the indi-
vidual’s lifetime.
Finally, no consensus has been established about a
standard model to determine multimorbidity patterns.
Published studies differ in the variables included, such as
the unit of analysis selected (patients versus diseases),
the statistical method for grouping diseases (factor ana-
lysis vs. cluster analysis), diseases included (chronic and/
or acute), and number of diseases considered [8, 9].
Nevertheless, non-hierarchical cluster analysis assigns
patients into a specified number of clusters [10]. The
results are less susceptible to outliers in the data, the
influence of the distance measure chosen, or the inclu-
sion of inappropriate or irrelevant variables. Some non-
hierarchical cluster analysis methods, like k-means, use
algorithms that do not need a distance matrix and can
analyse extremely large data sets [10–12].
The aim of this study was to identify multimorbidity
patterns over a six-year study period in electronic health
records from a Mediterranean urban population older
than 65 years and with multimorbidity, attended in pri-
mary health care centres in Barcelona (Spain).
Methods
Design, setting, and study population
A cohort study with a cross-sectional analysis was car-
ried out in each year of the study period, from 2009 to
2014, in Barcelona, Catalonia (Spain), a city of Mediter-
ranean region with 1,619,337 inhabitants (31/12/2009)
[13]. The Spanish National Health Service provides uni-
versal coverage, financed mainly by tax revenue. The
Catalan Health Institute (CHI) manages 50 primary
health care centres (PHCs) in Barcelona that represent
74% of the population [14]. The CHI’s Information Sys-
tem for Research in Primary Care (SIDIAP) contains the
clinical information as electronic health records (EHR)
recorded by its PHCs since 2006 [15–17].
Inclusion criteria were 65–94 years of age on 31
December 2009 and at least one PHC visit during the 6-
year study period. From the initial sample of 206,146
(Fig. 1), we excluded people who moved or otherwise
sought care outside the CHI system. The only reason to
exit the cohort was death (n = 24,013), and no new partici-
pants were introduced during the study period.
Prevalence of individual conditions varies with age, as
does multimorbidity and disease patterns. In order to ob-
tain a more homogenous sample in terms of multimorbid-
ity, we focused on patients from Barcelona city with
multimorbidity, defined as 2 or more diagnoses of chronic
disease active as of 31 December 2009. We obtained infor-
mation on that population during 6 years and analysed
the data 6 times at cross-sectional time points, every
December from 2009 to 2014. However, mortality data
were obtained 5 times, from 2010 to 2014.
Coding and selection of diseases
Diseases are coded in SIDIAP using International Classi-
fication of Diseases version 10 (ICD-10). We mapped
ICD-10 codes to International Classification of Primary
Care, second edition (ICPC-2) codes in order to select
chronic diseases by O’Halloran criteria [18] based on the
ICPC-2. We only considered chronic diseases with a
prevalence over 1% to avoid spurious associations and
obtain epidemiologically coherent patterns. Chronic dis-
eases were coded as a dichotomous variable.
Variables
The unit of measurement was the diagnosis (values: 1 for
present, 0 for absent). Other variables recorded for each
patient were the following: number of different diseases
(chronic diseases active on 31 December each year), age
groups in 2009 (65–79; ≥80), and sex (women, men).
Statistical analysis
Data access: Data were obtained from SIDIAP after the
study was authorized. All authors were granted access to
the database. No missing values were handled, as sex
and age were universally recorded, so there were no
missing values and no missing data were imputed.
Wrong codes for sex-specific diagnoses and diagnoses
with inconsistent dates were excluded.
Descriptive analysis
Analyses were stratified by sex and age. Descriptive sta-
tistics were used to summarize overall information. Cat-
egorical variables were expressed as frequencies
(percentage) and continuous as mean (Standard devi-
ation, SD) or median (interquartile range, IQR). Chi-
square test and Mann-Whitney test were used to assess
differences between age groups by sex.
Prevalence of each chronic disease was calculated for
each year in order to study the evolution over time.
Multimorbidity patterns were identified using two steps:
1) multiple correspondence analysis (MCA) and 2) k-
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means clustering. For every year of study (2009–14),
MCA and k-means analysis included only those individ-
uals that were alive as of 31 December each year.
Multiple correspondence analysis
This data analysis technique for nominal categorical data
was used to detect and represent underlying structures
in the data set. The MCA method allows representation
in a multidimensional space of relationships between a
set of dichotomous or categorical variables, in our case
diagnoses, that would otherwise be difficult to observe
in contingency tables and to show groups of patients
with the same characteristics [19, 20]. MCA also allows
the direct representation of patients as points (coordi-
nates) in geometric space, transforming the original bin-
ary data to continuous data. The MCA analysis was
based on the indicator matrix. Optimal number of
dimensions extracted and percentages of inertia were
determined by scree plot.
k-means clustering
From the geometric space created in MCA, patients
were classified in clusters according to proximity criteria
using the k-means algorithm with random initial cen-
troids. Clusters centres were obtained for each cluster.
Optimal number of clusters (k) was assessed according
to Calinski Harabaz criteria, using 100 iterations. The
optimal number of clusters is the solution with the high-
est Calinski-Harabaz index value. To assess internal
cluster quality, cluster stability of the optimal solution
was computed using Jaccard bootstrap values with 100
runs [10]. “Highly stable” clusters should yield average
Jaccard similarities of 0.85 and above.
Multimorbidity patterns
To describe multimorbidity patterns, frequencies and
percentage of diseases in each cluster were calculated.
Observed/expected (O/E) ratios were obtained by divid-
ing disease prevalence in the cluster by disease preva-
lence in each age group, by sex. To define a specific
pattern, we considered those diseases with an intra-
cluster prevalence ≥20% and an over-expression with O/
E ratio ≥ 2 [21]. The names of patterns are related to the
main system affected in each cluster.
Descriptive statistics of age and number of diagnoses
per each cluster were also obtained. Clinical criteria were
used to evaluate the consistency and utility of the final
cluster solution, based on clusters previously described
in the literature and a consensus opinion drawn from
the clinical experience of the research team (3 family
physicians and 2 epidemiologists engaged in daily patient
care). Stability in the patterns was considered as the
number of persons staying in the same pattern in 2014,
as well as the percentage of people who remained in the
same pattern at the end of the study compared to 2009.
The consistency of multimorbidity patterns was
established by analysing the number (percentage) of
people who remained stable within the cluster during
the study period.
The analyses were carried out using SPSS for Win-
dows, version 18 (SPSS Inc., Chicago, IL, USA) and R
version 3.3.1, procedures FactorMineR, fpc, and vegan(R
Foundation for Statistical Computing, Vienna, Austria).
Results
Out of 206,146 persons analysed at the beginning of the
study in 2009, 190,108 (92.2%) fulfilled multimorbidity
criteria (Fig. 1) and 59.8% were women. The mean age at
the beginning of the study was 71.8 (SD 4.35) years for
Fig. 1 Flow chart of the study
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the group 65–79 years old, and 84.2 years (SD 3.46) for
the group over 80. In 2009, 31.2% to 39.1% of the popu-
lation had fewer than 5 chronic diseases, while 40.2% to
42.3% had 6 to 9 diseases and 20.7% to 28.2% had re-
ceived more than 10 diagnoses. The median number of
diseases was 7 (IQR 5–10) for women and for men older
than 80 years; the younger men (aged 65–79 years) had
a median of 6 diseases (IQR 4–9) (Table 1).
Chronic diseases prevalence
Hypertension, uncomplicated was the most prevalent
chronic disease in all groups over the period of time
studied, followed by Lipid disorder. In the group aged
65–79 years, uncomplicated hypertension affected 69%
of women and 68% of men in 2009, and lipid disorder
affected 57.7% and 49.4%, respectively. Other prevalent
diagnoses for women in this age group in 2009 were
Osteoporosis (32.6%), Obesity (29.2%), and Depressive
disorder (27.3%); among men, ageing-related diseases
were prevalent, including Benign prostatic hypertrophy
(41.6%), Cataracts (21.4%), and Diabetes, non-insulin-
dependent (30.8%). The top 10 chronic diseases for
women and men throughout the study period are shown
in Fig. 2. Few changes in prevalence were observed over
the 6 years analysed.
K-means clustering
Using the Calinski criterion, six clusters were considered
as the optimal solution for both age and sex strata. Aver-
age Jaccard bootstrap values for both women and men
were 0.85 and above.
Multimorbidity patterns
For each of the four groups studied (two age groups of
men and women), 6 clusters were identified using the k-
means method. The first pattern, formed by only the
most prevalent diseases, was named the “nonspecific”
pattern; the remaining 5 patterns were specific to
Musculoskeletal, Endocrine-metabolic, Digestive/digest-
ive-respiratory, Neuropsychiatric, and Cardiovascular
diseases, in decreasing order depending on the percent-
age of the population included [see Additional files 1, 2].
The first cluster had the largest percentage of the
sample, both women and men: 35.6 and 36.7% of those
aged 65–79 years, 34.3–34.1% of those aged 80 and older
respectively [see Additional files 1-4]. For women, the
Table 1 Number of diseases, stratified by sex and age group
Patients included in the analysis in 2009, N = 190,108
Women Men
65–79 years ≥80 years 65–79 years ≥80 years
Total, n(%) 80,208 (42.2) 33,442 (17.6) 59,331 (31.2) 17,127 (9.0)
Number of diagnoses*, n(%)
2 4249 (5.3) 1595 (4.8) 3770 (6.4) 782 (4.6)
[3–5] 22,491 (28.1) 8688 (26.0) 19,429 (32.7) 4534 (26.5)
[6–9] 32,663 (40.7) 13,732 (41.0) 23,846 (40.2) 7252 (42.3)
≥ 10 20,805 (25.9) 9427 (28.2) 12,286 (20.7) 4559 (26.6)
Median number of diagnoses (IQR)** 7 (5–10) 7 (5–10) 6 (4–9) 7 (5–10)
Number of diagnoses included in cluster analysis*** 83 85 84 85
Patients included in the analysis in 2014, N = 166,095
Women Men
70–79 years ≥80 years 70–79 years ≥80 years
Total n(%) 51,835 (31.2) 49,940 (30.1) 38,127 (22.9) 26,193 (15.8)
Number of diagnoses*, n(%)
2 3220 (6.2) 2026 (4.1) 2811 (7.4) 1125 (4.3)
[3–5] 16,662 (32.1) 12,144 (24.3) 13,879 (36.4) 6818 (26.0)
[6–9] 21,334 (41.2) 21,316 (42.7) 15,119 (39.6) 11,333 (43.3)
≥ 10 10,619 (20.5) 14,454 (28.9) 6318 (16.6) 6917 (26.4)
Median number of diagnoses (IQR)** 6 (4–9) 7 (5–10) 6 (4–8) 7 (5–10)
Number of diagnoses included in cluster analysis*** 80 84 80 82
Abbreviations: IQR Inter-quartile range
*Chi-square test; all p-values < 0.001
**Mann-Whitney test; P < 0.001
***Chronic diseases with >1% prevalence
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top 3 diagnoses throughout the study period were
Hypertension, uncomplicated; Lipid disorder; and Osteo-
porosis. In the older group, Osteoarthritis, other was
added to the list for the first year and Cataract for the
other 5 years analysed [see Additional files 1-3].Similarly
for men, three diseases predominated in the Nonspecific
pattern throughout the study period: Hypertension,
uncomplicated; Lipid disorder, and Benign prostatic
hypertrophy. In older men, these diseases were
joined by Diabetes, non-insulin dependent in the first
year, adding Cataract in the remaining 5 years [see
Additional files 2, 4]. There was no over-represented
disease in these groups (O/E ratio ≥ 2).
Few variations were detected in terms of prevalence
and O/E ratios for the elements of a specific cluster, as
shown in the example presented in Tables 2 and 3. A
pattern observed in women aged 65–79 years was la-
belled the Neuropsychiatric pattern (Table 2). Some
neurological diseases were over-represented in 2009,
such as Dementia (O/E ratio 5.98) or Stroke/cerebrovas-
cular accident (O/E ratio 4.81), with a prevalence ≥20%.
Other over-represented diseases (O/E ratio ≥ 2) had a
prevalence <20% and bear little relation to the main sys-
tem affected, such as Ischaemic heart disease without
angina (O/E ratio 4.27, prevalence of 13.9%) or Athero-
sclerosis/peripheral vascular disease (O/E ratio 3.08,
prevalence of 9.6%). A large number of patients (in the
Table 2, 42.5% of women aged 65–79 years) stayed in
the same pattern from baseline until the end of the study
period. The rest of these percentages are presented in
[see Additional files 1, 2].
Table 3 shows men aged 65–79 years with the Neuro-
psychiatric pattern, containing almost the same diseases
as the homologous pattern in women. Differences be-
tween the patterns are mainly sex-related diseases such
as Benign prostatic hypertrophy.
Following the same method as these two examples, it
can be observed that chronic diseases included in each
pattern at the beginning of the sample mostly persisted
throughout the 6 years analysed. Some variations were ob-
served, such as chronic disease leaving the pattern when it
did not meet the inclusion criteria, sometimes only by a
few decimal points that decided whether a disease
remained in a pattern or not [see Additional files 1-4].
Fig. 2 Prevalence of chronic disease across the study period per each age group, stratified by sex
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Among women aged 80 and older, as in the younger
group, we defined six clusters (Nonspecific and 5 specific
multimorbidity patterns) with the same names, even if the
diseases varied, because the main system affected was the
same. The Muskuloskeletal, Endocrine-metabolic, Digest-
ive and Cardiovascular patterns showed changes in 1 or 2
diseases, but the Neuropsychiatric pattern had added 4
diseases to the cluster by the end of the study period [see
Additional file 3].
Several differences were observed in the older group
of men, as well. First, the Endocrine-metabolic pattern
in this age group was defined by diseases localized in
the Cardiovascular patterns in men aged 65–79 years.
Secondly, the Digestive pattern incorporated respiratory
diseases, becoming the Digestive-respiratory pattern (as
in the last year analysed in men 65–79 years), com-
posed of 9 more chronic diseases than the Digestive
pattern. Thirdly, the Neuropsychiatric and Cardiovascu-
lar patterns lost some diseases. Finally, no important
changes were found in the Musculoskeletal pattern [see
Additional file 4].
Furthermore, the percentage of patients whose mul-
timorbidity pattern remained stable exceeded 42.5%
for all patterns per each sex and age group. The Non-
specific patterns had the highest values for stability at
the end of the period for all groups except men aged
Table 2 Example of multimorbidity pattern: neuropsychiatric pattern considering observed/expected ratio in one cluster across
women aged 65–79 years
Neuropsychiatric pattern 2009 2010 2011 2012 2013 2014
Number of persons in the cluster n = 8242 n = 7493 n = 6770 n = 6042 n = 5360 n = 4688

























K86 Hypertension, uncomplicated 70.4 1.02 69.8 1.02 68.7 1.01 68.6 1.03 68.6 1.04 70.8 1.09
T93 Lipid disorder 67.6 1.17 68.4 1.18 68.1 1.17 67.9 1.16 68.4 1.17 70.6 1.21
P76 Depressive disorder 53.5 1.96 53.7 1.97 53.1 1.95 53.4 1.97 51.3 1.90 49.2 1.86
L95 Osteoporosis 39.5 1.21 39.9 1.22 40.0 1.23 39.3 1.22 39.2 1.24 39.2 1.27
P70 Dementia 32.4 5.98 30.8 6.31 30.1 6.79 27.9 7.05 25.4 7.33 21.0 6.94
L91 Osteoarthritis. other 31.8 1.18 31.1 1.16 30.1 1.13 30.4 1.16 29.5 1.14 29.3 1.15
T90 Diabetes. non-insulin dependent 31.0 1.38 30.9 1.40 30.6 1.40 32.8 1.52 33.7 1.60 37.4 1.81
F92 Cataract 29.4 1.15 29.2 1.16 29.1 1.18 29.2 1.22 28.2 1.23 26.4 1.22
K90 Stroke/cerebrovascular accident 23.5 4.81 23.1 4.94 22.4 5.02 21.5 5.11 20.2 5.08 16.9 4.50
P71 Organic psychosis, other 16.0 5.72 16.2 6.06 16.0 6.25 15.8 6.46 15.5 6.61 14.6 6.66
K76 Ischaemic heart disease without
angina
13.9 4.27 13.9 4.47 13.6 4.57 14.2 5.04 15.4 5.68 17.9 7.00
K91 Cerebrovascular disease 12.9 6.05 12.5 6.11 12.4 6.23 12.4 6.33 12.4 6.55 11.5 6.36
N87 Parkinsonism 12.8 6.62 11.9 6.51 12.2 7.00 11.6 7.12 11.7 7.47 11.1 7.72
N99 Neurological disease, other 11.6 4.63 11.9 4.85 11.8 4.88 11.8 5.00 11.0 4.78 10.7 4.86
K92 Atherosclerosis/ peripheral vascular
disease
9.6 3.08 9.6 3.17 9.6 3.30 9.6 3.45 9.4 3.47 11.4 4.36
K89 Transient cerebral ischaemia 9.3 3.67 9.1 3.74 8.6 3.69 8.7 3.90 8.0 3.77 6.9 3.45
K74 Ischaemic heart disease with angina 8.7 3.84 8.9 3.97 8.6 4.03 9.0 4.48 9.1 4.81 11.4 6.54
K75 Acute myocardial infarction 7.9 4.79 8.0 5.11 7.7 5.16 7.8 5.60 8.7 6.53 9.6 7.61
N88 Epilepsy 6.4 5.83 6.5 6.08 6.9 6.45 6.6 6.27 6.4 6.28 – –
B81 Anaemia. Vit B12/folate deficiency 4.0 2.83 3.7 2.74 3.6 2.78 3.5 2.86 3.5 3.09 2.9 2.80
F83 Retinopathy – – 5.5 2.12 5.9 2.32 7.2 2.87 7.2 2.96 9.8 4.13
N94 Peripheral neuritis/neuropathy – – – – – – 5.3 2.15 5.5 2.28 7.0 2.98
T82 Obesity – – – – – – 21.1 0.72 21.8 0.74 23.0 0.79
B82 Anaemia. other/unspecified – – – – – – – – 13.1 2.09 13.9 2.46
F84 Macular degeneration – – – – – – – – – – 3.2 2.24
aPeople who stay in the same cluster during the period of study
bPrev: prevalence
cO/E r: observed/expected ratio. Italic numbers indicate O/E r ≥ 2
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80 and older, for which the cardiovascular pattern
was the highest (Fig. 3).
Discussion
We explored multimorbidity patterns and their 6-year
evolution in people aged 65 years and older with
multimorbidity attended in PHC. The most prevalent
chronic diseases, Hypertension, uncomplicated and Lipid
disorder, were represented in all clusters in all four
groups (i.e., men and women aged 65–79 and ≥80 years).
We found 6 clusters per group, 5 of them with a specific
pattern related to an organic system: Musculoskeletal,
Endocrine-metabolic, Digestive/Digestive-respiratory, Neuro-
psychiatric and Cardiovascular patterns. We analysed
multimorbidity patterns over 6 years and found that they
remained quite similar from the beginning to the end of
the study period.
We observed a high prevalence of multimorbidity in
our population sample, with a higher proportion for
women, as in other published studies [5, 8] and described
6 patterns in each study group. In addition, the prevalence
of chronic diseases and multimorbidity patterns was
similar to previous studies in Catalonia [22] and in
other developed countries [23–25]. In a separate
study in the same sample, we analysed mortality rates
and observed higher mortality among men with
Digestive-respiratory patterns and among women with
Cardiovascular pattern [26].
Table 3 Example of multimorbidity pattern: neuropsychiatric pattern considering observed/expected ratio in one cluster across men
aged 65–79 years
Neuropsychiatric pattern 2009 2010 2011 2012 2013 2014
Number of persons in the cluster n = 5956 n = 5644 n = 5080 n = 4483 n = 3819 n = 3274

























K86 Hypertension, uncomplicated 67.3 0.99 70.0 1.03 71.0 1.05 68.9 1.02 68.1 1.02 66.2 0.99
T93 Lipid disorder 54.5 1.10 58.6 1.17 60.6 1.20 59.9 1.18 60.3 1.18 58.7 1.15
Y85 Benign prostatic hypertrophy 45.7 1.10 43.9 1.05 42.4 1.01 42.4 1.02 42.9 1.03 44.5 1.08
T90 Diabetes, non-insulin dependent 37.8 1.23 42.5 1.39 45.5 1.49 43.2 1.43 42.1 1.40 38.2 1.28
K90 Stroke/cerebrovascular accident 34.9 4.31 35.4 4.56 35.5 4.73 35.0 4.86 35.3 5.11 35.5 5.34
P76 Depressive disorder 34.1 3.11 32.1 2.95 30.4 2.83 31.4 2.94 31.9 3.04 32.3 3.19
P70 Dementia 28.2 6.56 24.3 6.24 22.2 6.32 22.2 6.84 21.5 7.52 21.7 8.73
F92 Cataract 23.8 1.11 24.1 1.14 24.3 1.16 23.4 1.14 23.7 1.20 21.2 1.13
K76 Ischaemic heart disease without
angina
21.5 2.12 24.0 2.42 24.4 2.52 24.4 2.57 22.5 2.44 20.0 2.23
K92 Atherosclerosis/peripheral vascular
disease
19.6 2.16 23.4 2.63 25.2 2.92 23.7 2.83 22.6 2.78 20.3 2.60
K91 Cerebrovascular disease 19.4 5.84 20.1 6.08 20.9 6.46 20.8 6.57 21.4 6.90 21.2 7.07
N87 Parkinsonism 17.3 6.74 15.0 6.14 13.6 5.88 13.6 6.12 13.9 6.66 14.2 7.10
K75 Acute myocardial infarction 13.5 2.06 15.8 2.47 15.6 2.50 15.8 2.62 14.9 2.52 12.8 2.28
N99 Neurological disease, other 13.5 5.08 13.0 4.96 12.8 4.98 13.3 5.24 13.9 5.65 14.7 6.22
P71 Organic psychosis, other 13.5 6.13 12.3 5.77 11.7 5.66 11.4 5.76 12.0 6.35 12.6 6.99
K89 Transient cerebral ischaemia 11.1 3.58 10.6 3.52 10.3 3.54 9.8 3.50 9.7 3.63 9.0 3.62
K74 Ischaemic heart disease with angina 10.3 2.35 11.1 2.58 11.3 2.71 11.9 2.93 11.1 2.79 9.7 2.50
N88 Epilepsy 8.2 6.13 7.4 5.61 7.1 5.43 7.8 6.06 8.5 6.69 9.1 7.33
A04 Weakness/tiredness. General 6.4 2.63 6.1 2.50 6.0 2.53 5.7 2.51 5.9 2.83 5.7 3.13
B81 Anaemia. Vit B12/folate deficiency 4.0 2.63 3.9 2.65 3.9 2.79 3.1 2.39 2.8 2.20 2.6 2.12
B82 Anaemia. other/unspecified – – 14.5 2.01 14.8 2.13 13.7 2.08 – – – –
F83 Retinopathy – – 6.5 2.13 7.4 2.45 6.6 2.17 6.4 2.09 – –
N94 Peripheral neuritis/neuropathy – – 6.2 2.07 6.5 2.22 6.6 2.25 6.5 2.28 5.7 2.07
U99 Urinary disease. Other – – 20.4 1.22 20.3 1.24 – – – – – –
aPeople who stayed in the same cluster throughout the period of study
bPrev: prevalence
cO/E r: observed/expected ratio. Italic numbers indicate O/E r ≥ 2
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In both age groups, both men and women had the
same 5 multimorbidity pattern names plus one add-
itional cluster: a Digestive disease pattern in women and
a Digestive-respiratory pattern in men. This difference is
probably related to the smoking and alcohol habits that
were more common among men than among women in
the age groups studied [27]. The differences observed be-
tween age groups were related to disease prevalence and
O/E ratio; no significant differences between men and
women were found in the systems that were most com-
monly affected by the prevalent diseases. As a result, fu-
ture clinical guidelines could focus on improving common
management of multimorbidity in all older patients.
It is particularly noteworthy that more than 50% of
those showing the Nonspecific pattern remained in that
same pattern across the period analysed, without moving
on to a specific pattern; a few degenerative diseases were
added in the older groups. In addition, this first (Nonspe-
cific) cluster was defined by highly prevalent diseases,
with no over-represented chronic diseases, so that the
association between diseases could exist by chance. Con-
sequently, this first cluster showed that a considerable
portion of the sample had no system-specific pattern.
In contrast, across the specific patterns we also observed a
large proportion (range from 42.5 to 64.7%) of people
remaining stable (in terms of chronic disease prevalence) in
the same pattern. Maximum stability was observed for the
Nonspecific pattern in both groups aged 65 to 79 years and
in older women; for men aged 80 and older, the Cardiovas-
cular pattern showed the greatest stability. Moreover, some
people changed from one pattern to another but the multi-
morbidity pattern kept mostly stable during the 6 years stud-
ied, confirming the long-term stability of the multimorbidity
pattern composition. In view of these results, an association
could be hypothesized between multimorbidity and specific
genetic conditions, as well as previously suggested associa-
tions with lifestyle and environmental conditions [28].
Estimates of multimorbidity pattern prevalences differ
deeply in the literature because of variations in methods,
data sources and structures, populations and diseases
studied. Although this makes it challenging to compare
study results [5, 29, 30], there are some similarities between
the present and previous studies. For instance, the most
common organic systems affected in previous studies of
multimorbidity patterns were cardiovascular/metabolic,
neuropsychiatric (mental health), and musculoskeletal [30].
Our study found patterns affecting these same organic sys-
tems; however, it offers another point of view for defining
multimorbidity patterns. Cluster analysis shows the com-
plexity of multimorbidity in persons aged 65 years and
older and is likely to be helpful in shaping future strategies
to continue studying this important health issue.
Previous studies have analysed no more than four years
of data [29], compared to six years of information about the
evolution of a multimorbidity pattern in our study. As a re-
sult, we identified long-term stability in multimorbidity pat-
terns, observing some differences between age groups,
related to prevalence and O/E ratio in chronic diseases.
Useful information can be extracted from our study for the
monitoring and treatment of each multimorbidity pattern.
Fig. 3 Sample corresponding to each pattern and people remaining in that pattern at the end of the study
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Strengths and limitations
A major strength of this study is the analysis of a large,
high-quality EHR database, representative of a large
population. In the context of a national health system
with universal coverage, EHR data have been shown to
yield more reliable and representative conclusions than
those derived from survey-based studies [25]. The inclu-
sion of all chronic diagnoses registered in EHR contrib-
uted to a more accurate analysis of the multimorbidity
patterns in this population. Moreover, the use of data
collected by the primary health care system increased
the external validation of the information extracted be-
cause primary care centres in Barcelona attended more
than 70% of the population at least once a year during
the study period. As the nonspecific pattern contained
well-known chronic diseases with established clinical
guidance, the information extracted is relevant but less
useful in clinical practice than the specific patterns de-
fined. The long time period observed provided informa-
tion on the stability of the patterns during six years,
enabling us to focus on creating better strategies to ad-
dress all five specific patterns in terms of prevention,
diagnosis, and treatment of these systemic clusters of
prevalent diseases.
A number of limitations must be taken into account
as well. First, EHR accuracy depends on the data entered
by each general physician or nurse, and EHR systems are
not designed as general-purpose research tools [31]. An-
other weakness could be the attention only to chronic
diseases, which precludes awareness of acute diseases or
bio-psychosocial factors [2]. Nonetheless, the inclusion
of a wide range of diseases makes it possible to find mul-
timorbidity patterns not previously obtained and in-
creases complexity in terms of assembling patterns.
Finally, we did not have data on cause of death.
In addition, using MCA can produce low percentages
of variation on principal axes, complicating the choice of
the number of dimensions to retain. We assumed a five-
dimension solution, using the elbow rule in the scree
plot to have the most accurate solution possible without
including an unwieldy number of dimensions in the ana-
lysis [19]. Although we did not retain the total variance
of the dataset, clustering techniques can be applied to
the reduced dataset while preserving its complexity.
The strength of using k-means cluster analysis is that
the results are less susceptible to outliers in the data, the
influence of the chosen distance measure, or the inclu-
sion of inappropriate or irrelevant variables. The method
can also analyse extremely large data sets (as in this
study), as no distance matrix is required. On the other
hand, some disadvantages of the method are that differ-
ent solutions can occur for each set of seed points and
there is no guarantee of optimal clustering [11]. To
minimize this shortcoming, we tested the internal
validity of our solution using bootstrap methods [32],
and the results were highly stable (Jaccard > 0.85). How-
ever, the method is not efficient when a large number of
potential cluster solutions are to be considered [11]; to
address this limitation, we computed the optimal num-
ber using analytical indexes like Calinski Harabasz [33].
Future research
With this confirmation of the stability of multimorbidity
patterns across age groups, sex, and time, some actions
could be considered to improve multimorbidity manage-
ment. For instance, clinical guidance could encompass a
specific pattern to deal with its complexity rather than
creating multiple guidelines for each of the chronic dis-
eases. Relevant information could be extracted from our
study for the monitoring and treatment of each multi-
morbidity pattern. Finally, genetic factors, as well as
socioeconomic status, should be taken into account in
future studies.
Conclusions
We identified a very large proportion of people over
65 years with multimorbidity, distributed in six clusters;
five affected a specific system in the body and one had a
nonspecific pattern. The major portion of the sample fit
this last pattern, which had few diseases; this finding
could be related to genetic or social characteristics of
the sample. On the other hand, stability in a specific pat-
tern over an extended time period might give us the in-
formation needed to take a new approach and improve a
patient’s situation. For instance, a new clinical practice
guideline could be developed to control a combination
of chronic diseases rather than each one individually.
As the prevalence of chronic diseases was stable over
the period studied, multimorbidity patterns also became
firmer. Therefore, the k-means technique is useful to
analyse multimorbidity patterns in real-world data.
The observation that multimorbidity patterns are con-
stant over time is very useful for the specific clinical
management of each patient who fits a specific multi-
morbidity pattern. Further studies using this method in
other groups of patients should be performed to validate
the results obtained.
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